共 24 条
[12]
Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients A Real-World Analysis of 49 485 Eyes
[J].
OPHTHALMOLOGY RETINA,
2020, 4 (01)
:19-30
[13]
Comparison and Repeatability of High Resolution and High Speed Scans from Spectralis Optical Coherence Tomography Angiography
[J].
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY,
2020, 9 (10)
:1-10
[14]
Changes in the OCT angiographic appearance of type 1 and type 2 CNV in exudative AMD during anti-VEGF treatment
[J].
BMJ OPEN OPHTHALMOLOGY,
2019, 4 (01)
[17]
PREDICTORS OF RECURRENT EXUDATION IN CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION DURING A TREATMENT-FREE PERIOD
[J].
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES,
2020, 40 (11)
:2158-2165
[18]
Incidence and Clinical Practice of Exudative Age-related Macular Degeneration A Nationwide Population-Based Cohort Study
[J].
OPHTHALMOLOGY SCIENCE,
2022, 2 (02)
[19]
VASCULAR REMODELING OF CHOROIDAL NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY VISUALIZED ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY
[J].
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES,
2019, 39 (03)
:548-557
[20]
Vascular maturity of type 1 and type 2 choroidal neovascularization evaluated by optical coherence tomography angiography
[J].
PLOS ONE,
2019, 14 (04)